CJC-1295 with DAC synergetics-peptides Research interest in VIP includes

Research interest in VIP includes its potential influence on gut health

This axis governs hormone signalling pathways involved in reproductive function and endocrine balance

It has been studied in preclinical and neurological research for its potential role in cognitive processes

and tumour biology

It remains a subject of interest in studies examining neuropeptide modulation and brain performance pathways

CJC-1295 with DAC synergetics-peptides Research interest in VIP includesCJC 1295 with DAC is a synthetic peptide based on growth hormone releasing hormone (GHRH), modified with a Drug Affinity Complex (DAC) to extend its half life in laboratory settings. This modification allows it to bind to serum proteins, resulting in prolonged activity during scientific studies. In research environments, CJC 1295 with DAC has been studied for its potential to influence growth hormone secretion and IGF 1 levels, both of which are